top of page
.png){kind=logo}
NEWS & BLOGS
Blog: Blog2
FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/do-i-qualify-covid-19-vaccine-booster-and-which...
Provision Consulting Group
Jan 3, 20225 min read
Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S Market by Biden-Harris Administration
FDA Authorizes Roche and Siemens At-Home Tests, Which Went Through New Biden Administration Accelerated Review Program; Will Bring Tens...
Provision Consulting Group
Dec 30, 20213 min read
FDA Webinar, OTC Sunscreen Deemed Final Order (DFO)
On December 15, 2021, FDA offered a webinar for OTC Sunscreen and discussed Deemed Final Order(DFO) for OTC sunscreen drugs. Active...
Provision Consulting Group
Dec 28, 20211 min read
FDA Urges Manufacturers to Develop Solutions for iPLEDGE REMS Website
https://www.facebook.com/FDA FDA is aware that patients, prescribers, and pharmacies are experiencing difficulties with...
Provision Consulting Group
Dec 27, 20211 min read
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and...
Provision Consulting Group
Dec 22, 20214 min read
How Nail Products Are Regulated?
It is important to use nail products safely, following labeled directions and paying attention to any warning statements. The following...
Provision Consulting Group
Dec 22, 20217 min read
FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations
Action FDA has approved Xarelto (rivaroxaban) as tablets and an oral suspension to treat venous thromboembolism (VTE), or blood clots...
Provision Consulting Group
Dec 21, 20213 min read
Fulfilling Essential Public Health Needs in 2022
By: Janet Woodcock, M.D., Acting Commissioner of Food and Drugs The U.S. Food and Drug Administration’s response to the COVID-19 pandemic...
Provision Consulting Group
Dec 20, 20214 min read
FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years
Action FDA has granted accelerated approval for Oxbryta (voxelotor) tablets to treat sickle cell disease in pediatric patients aged four...
Provision Consulting Group
Dec 20, 20212 min read
FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease
Action FDA has granted accelerated approval for Tarpeyo (budesonide) delayed release capsules to reduce proteinuria (increased protein...
Provision Consulting Group
Dec 16, 20212 min read
bottom of page